What happens when you take rosuvastatin with niacin?
Rosuvastatin (Crestor) is a statin that lowers LDL cholesterol. Niacin is vitamin B3. In large amounts, 1 gram a day or more, niacin is also used to change blood fats, either as a prescription (such as Niaspan) or as a high-strength supplement. Rosuvastatin can injure muscle, and niacin at those amounts adds to that risk.
- Rosuvastatin can cause myopathy: muscle pain, tenderness or weakness with a rise in the muscle enzyme creatine kinase (CK).
- The Crestor label lists niacin at lipid-modifying doses (1 gram a day or more) among the drugs that increase the risk of myopathy and rhabdomyolysis.
- In rare cases, muscle injury becomes rhabdomyolysis, where damaged muscle releases proteins that can harm the kidneys.
- The label reports that cases of myopathy and rhabdomyolysis have occurred with this combination. It does not say how often.
- The label also says Asian patients may be at higher risk of myopathy on rosuvastatin, and that higher rosuvastatin doses carry more risk.
Why is this important?
This is a label warning, not a theoretical concern. The Crestor label asks prescribers to consider whether the benefit of adding cholesterol-dose niacin outweighs the higher risk of muscle injury, and to watch for muscle symptoms if they go ahead.
The size of the risk has not been measured with rosuvastatin itself. It was measured with simvastatin, another statin: in the HPS2-THRIVE trial, adding extended-release niacin raised definite myopathy about 4-fold, and muscle problems were far more common in participants in China than in Europe.
The extra risk also comes without a proven heart benefit. In two large trials of people already on a statin (simvastatin), adding niacin did not reduce heart attacks, strokes or other major vascular events. That is why niacin is now rarely added to a statin, and why the decision belongs to your prescriber.
What should you do?
The principle is simple: cholesterol-dose niacin is a medicine decision, not a supplement add-on, when you take rosuvastatin.
Before starting niacin: If you take rosuvastatin and are thinking about a high-strength niacin product for cholesterol, talk to your prescriber first. Mention if you are of Asian descent, are 65 or older, or have kidney or thyroid problems, since the label lists these as reasons for higher muscle risk.
Every day while on both: If your prescriber has decided the combination is right for you, take both exactly as prescribed and pay attention to your muscles, especially in the first weeks and after a dose increase of either one.
If symptoms appear: Contact your doctor promptly about unexplained muscle pain, tenderness or weakness, especially with fever, tiredness or dark urine. Do not stop or change rosuvastatin on your own; your doctor may check your CK level and decide what to change.
Which specific products are affected?
On the medication side, this applies to Crestor and generic rosuvastatin tablets.
On the niacin side, the label warning is about niacin (nicotinic acid) at 1 gram a day or more. That includes prescription extended-release niacin (Niaspan and generics), immediate-release niacin, and high-strength over-the-counter niacin sold for cholesterol. The small amounts of niacin in a standard multivitamin or B-complex are far below that level. Niacinamide (nicotinamide), a different form of vitamin B3 found in many multivitamins and skin products, is not used to lower cholesterol and is not the form the label describes. Read the Supplement Facts label for the form and the amount per serving.
The science behind it
The Crestor prescribing information on DailyMed (section 7.1) states that cases of myopathy and rhabdomyolysis have occurred with lipid-modifying doses of niacin (1 gram a day or more) taken with rosuvastatin. It tells prescribers to weigh the benefit against that risk and, if they use the combination, to monitor for muscle symptoms, particularly when starting and when raising the dose of either drug.
The best measured rate comes from a different statin. In HPS2-THRIVE, 25,673 adults with vascular disease on simvastatin were randomized to extended-release niacin with laropiprant or placebo. Definite myopathy occurred in 75 people on niacin versus 17 on placebo (risk ratio 4.4), and any myopathy was much more common in China (HPS2-THRIVE Collaborative Group, Eur Heart J 2013, PMID 23444397). Major vascular events did not fall (13.2 versus 13.7 percent) (N Engl J Med 2014, PMID 25014686), and in AIM-HIGH, adding niacin to simvastatin gave no extra benefit over 3 years (N Engl J Med 2011, PMID 22085343).
Rosuvastatin and extended-release niacin have been tested together for blood fats in smaller, shorter trials. In 270 people over 24 weeks, rosuvastatin alone was better tolerated than the combinations (Capuzzi DM, et al. Am J Cardiol 2003, PMID 12767421), and a 12-week study of 292 people, in which one of four groups took rosuvastatin with extended-release niacin, reported no drug-related myopathy (McKenney JM, et al. Atherosclerosis 2007, PMID 17239888). Trials this size and length cannot measure a rare muscle injury. What was not shown: no trial has measured the myopathy rate of niacin with rosuvastatin specifically, and the warning does not cover multivitamin amounts.
Frequently Asked Questions
Is the niacin in my multivitamin a problem with rosuvastatin?
The label warning is about niacin at 1 gram a day or more. Multivitamins contain far less. If you are unsure about a product, show the label to your pharmacist.
Why would anyone take niacin with a statin?
Niacin raises HDL cholesterol and lowers triglycerides, so it was once added to statins. In large trials, adding it to a statin did not reduce heart attacks or strokes and raised side effects, so it is now used far less.
Does flush-free or slow-release niacin avoid the problem?
Slow-release niacin does not: the large trial that measured the muscle risk used an extended-release form. Products sold as flush-free were not tested. Ask your pharmacist what form of niacin a product contains and how much.
Why does being of Asian descent matter?
The Crestor label says Asian patients may be at higher risk of myopathy on rosuvastatin, and in the simvastatin trial, muscle problems with niacin were much more common in participants in China.
What muscle symptoms should I watch for?
Unexplained muscle pain, tenderness or weakness, especially with fever, feeling unwell or dark urine. Contact your doctor promptly rather than waiting.
Is niacinamide the same as niacin?
No. Niacinamide is another form of vitamin B3 that is not used to lower cholesterol and is not the form the label warning describes.
Key takeaways
- Niacin at cholesterol-lowering amounts (1 gram a day or more) raises the risk of muscle injury with rosuvastatin, according to the Crestor label.
- The label reports cases of myopathy and rhabdomyolysis and asks prescribers to weigh the benefit and monitor for muscle symptoms.
- With simvastatin, adding extended-release niacin raised definite myopathy about 4-fold without reducing major vascular events.
- Multivitamin amounts of niacin, and niacinamide, are not what the warning is about.
- Report new muscle pain, weakness or dark urine promptly, and never change rosuvastatin on your own.
